Most studies in this regard have focused on a crosstalk between ERα and the transcription factor nuclear factor‐kappa B (NF‐κB), a key regulatory element of inflammatory responses associated with the development, progression, and therapy resistance in cancer [15, 16, 17]. This evidence concerns the gene ESR1 and cancer.